CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was raised to $80.00. Don't Miss our Black Friday Offers ...

We are America's leading health solutions company, delivering care in ways no one else can.

Piper Sandler analyst Jessica Tassan maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $64.00. The company’s shares closed last Friday at $58.01.

CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion. With the biggest players across the healthcare industry interested in making an offer, I only expect ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

(AP Photo/Marcio Jose Sanchez, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] CVS Health has added four new board members, including the CEO of a hedge fund that has been ...

Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year. The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times.